enero 15, 2020 |
MedRhythms Advances Pipeline of Neurologic Rehabilitation Products in Multiple Sclerosis, Parkinson’s Disease
(Reprint from CISION PR Newswire 1/14/2020) PORTLAND, Maine, Jan. 14, 2020 /PRNewswire/ — MedRhythms, a Portland, Maine-based digital therapeutics company that uses sensors, software, and music to measure and improve walking, today announced the advancement of its pipeline in multiple sclerosis (MS) and Parkinson’s disease (PD). Read more aquí.
Categories:
© 2025 Instituto Tecnológico de Maine. Todos los derechos reservados. Intimidad